Authors’ contributions {31b}
RA, MM
PP was the trial methodologist and drafted the manuscript. He also ensured all biostatistical analyses. SP supervised the trial conduct. MM contributed to the study design and helped in obtaining funding. LL was the pharmacist and organized treatment dispatch to centers. ST was the data manager of the trial, conceived the eCRF, and ensured data quality. RA, MAA, FR, MR, EB, OS, MC, FF, PB, OS, and KM contributed to the study design and recruited patients. JYM is responsible of the Lyon transplantation unit and helped in conceiving the study. ML is the chief investigator; he conceived the study, led the protocol development, obtained funding, and coordinated the trial. All authors read and approved the final version of the manuscript. Future publications, scientific communications, and reports related to this study will be carried out under the responsibility of the study’s principal investigator with the agreement of the associated investigators. The co-authors of the report and the publications will be the investigators and the physicians involved, in proportion to their contribution to the study, as well as the biostatistician and the associated researchers. The publication rules will follow international recommendations (N Engl J Med, 1997; 336:309-315).